MetLife Investment Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

MetLife Investment Management’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-83,329	Closed	-$211K	–	2853
2023 Q4	$211K	Hold	83,329	–	–	﹤0.01%	2219
2023 Q3	$199K	Hold	83,329	–	–	﹤0.01%	2210
2023 Q2	$192K	Hold	83,329	–	–	﹤0.01%	2296
2023 Q1	$212K	Buy	83,329 +18,380	+28%	+$52.7K	﹤0.01%	2186
2022 Q4	$163K	Sell	64,949 -16,171	-20%	-$45.1K	﹤0.01%	2373
2022 Q3	$235K	Hold	81,120	–	–	﹤0.01%	2187
2022 Q2	$367K	Buy	+81,120	New	+$483K	﹤0.01%	1875

MetLife Investment Management's SLGC Position: Q1 2024 in Review

MetLife Investment Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 83,329 shares — an estimated $211K sold.

MetLife Investment Management first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $367K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

MetLife Investment Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
MetLife Investment Management sold 83,329 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $211K.
MetLife Investment Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
MetLife Investment Management's SomaLogic, Inc. Class A Common Stock position peaked at $367K in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.